Hugh M. Cole, Chief Business Officer at Jounce Therapeutics, Inc. (JNCE), sold 9,673 shares at $6.65 ($67K) on 2022-01-10, disclosed to the SEC on 2022-01-11.
Open-market sale of $67k JNCE by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.30 | 3,468 | $25K | 38.0% |
| 2 | $6.65 | 6,205 | $41K | 62.0% |
| Total | $6.88 avg | 9,673 | $67K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-11 | $43K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |
| JNCE | SELL | 2020-01-10 | $20K | — | Filing → |